For years, doctors have known that ketamine can relieve severe depression incredibly fast (sometimes within hours). But one big question remained: what exactly happens in the brain when it works?
A new study published in Molecular Psychiatry may finally have the answer.
Researchers in Japan used advanced brain imaging to observe how ketamine affects AMPAR receptors (AMPAR receptors are key proteins that help brain cells communicate with each other). These receptors play an important role in how the brain adapts, learns, and regulates mood.
The study followed people with treatment-resistant depression – a form of depression that doesn’t respond to standard antidepressants. Brain scans showed that ketamine doesn’t change the brain uniformly. Instead, it adjusts receptor activity in very specific regions linked to mood and reward.
Some brain areas showed increased receptor activity, while others – particularly regions tied to negative mood signals – showed reduced activity. These changes closely matched improvements in patients’ symptoms.
In simple terms, ketamine appears to quickly reshape how brain cells communicate, helping restore healthier mood circuits.
Beyond explaining how ketamine works, the findings could help researchers develop better, more personalized depression treatments. In the future, brain scans might even help doctors predict which patients are most likely to benefit from ketamine therapy.
For millions of people living with treatment-resistant depression, that kind of insight could make a real difference.
Source: https://www.sciencedaily.com/releases/2026/03/260307213234.htm
